201 related articles for article (PubMed ID: 2596087)
21. [Apheresis in severe hypercholesterolaemia].
Graesdal A; Hovland A; Bjørbaek E
Tidsskr Nor Laegeforen; 2004 Apr; 124(8):1085-7. PubMed ID: 15114383
[TBL] [Abstract][Full Text] [Related]
22. Apheresis technologies for prevention and regression of atherosclerosis: clinical results.
Bambauer R; Schneidewind JM; Latza R
ASAIO J; 1999; 45(5):403-7. PubMed ID: 10503615
[TBL] [Abstract][Full Text] [Related]
23. Mobilisation of tissue cholesterol by apheresis.
Thompson GR
Prog Clin Biol Res; 1990; 337():183-7. PubMed ID: 2191311
[No Abstract] [Full Text] [Related]
24. [LDL-adsorption therapy of familial hypercholesterolemia].
Kobayashi J; Yoshida S
Nihon Rinsho; 1992 Jan; 50 Suppl():382-7. PubMed ID: 1578711
[No Abstract] [Full Text] [Related]
25. Direct adsorption of lipoproteins from whole blood by direct adsorption of lipoprotein apheresis: first experience in two hypercholesterolemic children.
Bayrakci US; Besbas N; Ozcebe O; Coskun T; Akgul E; Kutluk T; Bakkaloglu A
Ther Apher Dial; 2005 Dec; 9(6):469-72. PubMed ID: 16354278
[TBL] [Abstract][Full Text] [Related]
26. Long term effect of LDL apheresis on coronary heart disease.
Donner MG; Richter WO; Schwandt P
Eur J Med Res; 1997 Jun; 2(6):270-4. PubMed ID: 9182655
[TBL] [Abstract][Full Text] [Related]
27. Carotid artery wall shear stress after LDL-apheresis in familial hypercholesterolemia.
Bardelli M; Cominotto F; Fazio M; Ussi D; Bordin P; Petrucco A; Fabris B; Fischetti F; Lapasin R; Carretta R
Boll Soc Ital Biol Sper; 1994; 70(10-11):295-7. PubMed ID: 7702833
[No Abstract] [Full Text] [Related]
28. Low-density lipoprotein apheresis in children with familial hypercholesterolemia: follow-up to 21 years.
Palcoux JB; Atassi-Dumont M; Lefevre P; Hequet O; Schlienger JL; Brignon P; Roussel B
Ther Apher Dial; 2008 Jun; 12(3):195-201. PubMed ID: 18503695
[TBL] [Abstract][Full Text] [Related]
29. Role of LDL apheresis in a case of homozygous familial hypercholesterolemia.
Naveen T; Biswas A; Wig N; Soneja M; Jorwal P; Durga CS; Singla P; Chaudhary C; Baitha U
Drug Discov Ther; 2019; 13(1):59-61. PubMed ID: 30880324
[TBL] [Abstract][Full Text] [Related]
30. From plasma-exchange to LDL-apheresis: new developments in the treatment of familial hypercholesterolemia.
Postiglione A; Gnasso A; Mastranzo P; Montefusco S; Motti C; Gallotta G; Cortese C; Scarpato N
Beitr Infusionsther; 1988; 23():74-80. PubMed ID: 2484784
[No Abstract] [Full Text] [Related]
31. [H.E.L.P. apheresis and oxidative stress].
Pulawski E; Mellwig KP; Horstkotte D
Z Kardiol; 2003; 92(Suppl 3):III38-41. PubMed ID: 14663600
[TBL] [Abstract][Full Text] [Related]
32. [Reducing low density lipoprotein-cholesterol levels by apheresis].
Reiber I; Gógl A
Orv Hetil; 1994 Mar; 135(11):563-8. PubMed ID: 8159408
[TBL] [Abstract][Full Text] [Related]
33. Decrease of thyroid hormones in patients with familial hypercholesterolemia during dextran sulphate low-density lipoprotein apheresis.
Pintus S; Pintus P; Piras C; Loviselli A; Muntoni S
J Clin Apher; 1994; 9(2):124-5. PubMed ID: 7798159
[TBL] [Abstract][Full Text] [Related]
34. LDL-apheresis affects markers of endothelial function in patients with homozygous familial hypercholesterolemia.
Nenseter MS; Bogsrud MP; Græsdal A; Narverud I; Halvorsen B; Ose L; Aukrust P; Holven KB
Thromb Res; 2012 Nov; 130(5):823-5. PubMed ID: 22728023
[No Abstract] [Full Text] [Related]
35. Comparison of two low-density lipoprotein apheresis systems in patients with homozygous familial hypercholesterolemia.
Drouin-Chartier JP; Tremblay AJ; Bergeron J; Pelletier M; Laflamme N; Lamarche B; Couture P
J Clin Apher; 2016 Aug; 31(4):359-67. PubMed ID: 26011648
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo studies with different precipitate filter cartridges for H.E.L.P.-LDL-apheresis. Optimization of precipitate filter cartridges.
Morsch G; Maywald F; Wanner C
Bioseparation; 1995 Feb; 5(1):11-8. PubMed ID: 7766149
[TBL] [Abstract][Full Text] [Related]
37. Clinical applications of long-term LDL-apheresis on and beyond refractory hypercholesterolemia.
Mabuchi H; Higashikata T; Kawashiri MA
Transfus Apher Sci; 2004 Jun; 30(3):233-43. PubMed ID: 15172629
[TBL] [Abstract][Full Text] [Related]
38. Coronary atherosclerosis reduced in patients with familial hypercholesterolemia after intensive cholesterol lowering with low-density lipoprotein-apheresis: 1-year follow-up study. The Osaka LDL-Apheresis Multicenter Trial Group.
Kitabatake A; Sato H; Hori M; Kamada T; Kubori S; Hoki N; Minamino T; Yamada M; Kato T
Clin Ther; 1994; 16(3):416-28. PubMed ID: 7923308
[TBL] [Abstract][Full Text] [Related]
39. Patient tolerance regarding different low-density lipoprotein apheresis columns: frequent minor side effects and high patient satisfaction.
Hovland A; Hardersen R; Enebakk T; Mollnes TE; Lappegård KT
J Clin Lipidol; 2011; 5(1):45-9. PubMed ID: 21262506
[TBL] [Abstract][Full Text] [Related]
40. Effects on coronary atherosclerosis of long-term treatment of familial hypercholesterolemia by LDL-apheresis.
Mabuchi H; Koizumi J; Michishita I; Takeda M; Kajinami K; Fujita H; Inazu A; Uno Y; Shimizu M; Takeda R
Beitr Infusionsther; 1988; 23():87-96. PubMed ID: 2484787
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
